This inventor holds 1 USPTO granted patent. Top assignee: Biosignal Kutato-Fejlesztokft. Active years: 1996.
Company Filing History:
Years Active: 1996
Title: Miklos Idei: Innovator in Tumor-Inhibiting Pharmaceuticals
Introduction
Miklos Idei is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tumor growth-inhibiting compounds. His work focuses on innovative solutions for treating tumors and managing hormone secretion disorders.
Latest Patents
Miklos Idei holds a patent for "Tumor growth-inhibiting somatostatin analogues." This invention relates to tumor-inhibiting heptapeptide and octapeptide amide derivatives. The method described in the patent offers a treatment for mammals, including humans, suffering from tumors or excessive secretion of insulin, glucagon, or growth hormone.
Career Highlights
Miklos Idei is associated with Biosignal Kutato-Fejlesztokft, where he continues to advance his research and development efforts. His innovative approach has led to the creation of effective pharmaceutical solutions that address critical health issues.
Collaborations
Some of his notable coworkers include Imre Mezo and Zsolt Vadasz, who have contributed to his research endeavors. Their collaboration has fostered a productive environment for innovation in the pharmaceutical field.
Conclusion
Miklos Idei's work exemplifies the impact of innovation in medicine, particularly in the treatment of tumors and hormone-related disorders. His contributions continue to influence the pharmaceutical industry and improve patient outcomes.